ClinicalTrials.Veeva

Menu

Prevalence of Osteosarcopenic Obesity in Older Adults

I

Istanbul Medeniyet University

Status

Completed

Conditions

Osteoporosis
Osteopenia
Obesity
Sarcopenia

Study type

Observational

Funder types

Other

Identifiers

NCT04288401
IstanbulMU3

Details and patient eligibility

About

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Enrollment

460 patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age of 65 or over
  • Being had been examined for all the primary outcome measures (i.e. the results of primary outcomes must be in the patient's file)

Exclusion criteria

  • Severe cognitive dysfunction
  • not being able to walk independently for 4 m

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems